Newly diagnosed HIV+ men are embracing treatment more than ever before

The final Seroconversion Study Report has been released, revealing more HIV-positive gay and bisexual men are embracing treatment than ever before.

Gay and bisexual men who are newly diagnosed with HIV change their behaviour to reduce the chance of onward transmission, according to the results of a long-running Australian study released today.

The final Seroconversion Study Report found that HIV-positive men are now more likely to disclose their status, reduce the number of sexual partners they come into contact with, and use condoms during sex.

It also found that more newly diagnosed men are adopting treatment as prevention (TasP) than ever before.

The Seroconversion Study was led by the Kirby Institute and looked at the behavioural changes of HIV-positive men between 2007 and 2015, along with their understanding of the virus.

Research Associate at the Kirby Institute Ian Down believes there’s been a massive shift in the understanding around HIV treatment.

“I interviewed 100 men face-to-face and certainly back in 2007 they were quite skeptical about treatment,” he told the Star Observer.

“Some guys were reluctant to begin treatment early and some wanted to stay completely off it, because back then there was a fear of the side effects.

“But now it’s been demonstrated that there are improved health outcomes when people begin treatment immediately following their diagnosis – and people have the knowledge that there are individual health benefits as well as a reduced risk of transmission.”

Down attributes this shift to the increased information about treatment as prevention.

The Victorian AIDS Council (VAC) and Living Positive Victoria recently launched the Treat HIV Now campaign to encourage HIV-positive men to get early treatment.

Scroll to Top

Canada Post has provided notification of restarting their operations on December 17, 2024. As Canada Post ramps up and stabilizes their services, the BC-CfE will continue the following measures on an interim basis to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory will utilize private courier for delivery of outgoing reports and documents. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy will utilize private courier for delivery of medications. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)